Report Store | Pharma intelligence
  • My Account
    • 0Shopping Cart
  • $0.00
  • Disease analysis
    • Anemias
    • Bacterial infections
    • Bleeding disorders
    • Brain Cancer
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Cerebrovascular diseases
    • Dermatology
    • Diabetes and diabetic complications
    • Gastroenterology
    • Gastrointestinal cancer
    • Head and Neck Cancer
    • Hypertension
    • Immunology and Inflammation
    • Infectious Diseases
    • Ischemic heart disease
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Oncology overview
    • Market Spotlight
    • Mens Health
    • Neurology
    • Oncology
    • Ophthalmology
    • Other Hematological Cancers
    • Other metabolic diseases
    • Other Solid Cancers
    • Pain
    • Psychiatry
    • Respiratory
    • Rheumatology
    • Skin cancer
    • Thrombosis
    • Urological cancer
    • Vaccines
    • Viral infections
    • Women’s Health
  • Strategy analysis
    • Bleeding disorders
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Commercial Strategy
    • Dealmaking and R&D
    • Head and Neck Cancer
    • Hot Topics
    • Infectious Diseases
    • KOL Insight
    • Leukemia
    • Lung Cancer
    • Manufacturing
    • Market Access
    • Neurology
    • Oncology
    • Outsourcing
    • Pricing & Reimbursement
    • R&D
    • Regulatory & Therapeutic Area
    • Trends
    • Urological cancer
  • Company analysis
    • Big Pharma
    • Emerging Pharma
    • Hot Topics
    • Japan Pharma
    • M&A Analysis
    • Mid Pharma
  • Drug analysis
    • A
    • B-C
    • D-F
    • G-L
    • M-O
    • P-R
    • S-T
    • U-Z
  • MedTech analysis
    • Allergy
    • Autoimmune / Immunology
    • Cardiovascular
    • Dermatology
    • Endocrine
    • ENT / Dental
    • Gastroenterology
    • Hearing
    • Hematology
    • Infectious Diseases
    • Metabolic
    • Neurology
    • Obstetrics / Gynecology
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Osteoporosis
    • Psychiatry
    • Renal
    • Respiratory
    • Rheumatology
    • Urology
  • Opinion & analysis
    • Business Development
    • Business Management
    • Clinical Trials
    • Digital Health
    • Cybersecurity
    • Compliance & Risk
    • Digital patient management
    • Digital policy & regulation
    • Finance & Pricing
    • Healthcare Innovation
    • ICT and Health
    • Leadership
    • Legislation Regulation & Policy
    • Market Access
    • Market Intelligence
    • Medical
    • Pharmaceutical Device
    • Pharmaceutical Research
    • Strategy & Innovation
    • Tech companies & Data
    • Tech & Pharma
  • Blogs
  • Search
  • Menu
You are here: Home > MedTech analysis

MedTech analysis


loader
  • Sort by Date
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Click to order products ascending
  • Display 30 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page

  • U.S. Markets for Orthopedic Extremity and Soft Tissue Repair, September 2015

    $5,250.00

    The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury.

    September 1, 2015
    Find out more

  • U.S. Surgical Procedure Volumes

    $4,750.00

    This report presents the most common surgical procedures performed in the United States (U.S.) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.

    November 1, 2015
    Find out more

  • U.S. Patient Monitoring Devices Market, November 2015

    $5,250.00

    This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market.

    November 2, 2015
    Find out more

  • U.S. Markets for Minimally Invasive Benign Prostatic Hyperplasia and Prostatitis Therapies

    $4,750.00

    This analysis includes a discussion of products, current/forecast markets, competitors, and opportunites in the benign uterine condition therapy systems market, including global endometrial ablation systems, MR-guided focused ultrasound systems, uterine artery embolization systems, and hysteroscopes/fibroid removal systems.

    November 14, 2015
    Find out more

  • Global Spinal Implants Market

    $5,250.00

    Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis.  These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma.

    December 1, 2015
    Find out more

  • U.S. Markets for Drug and Fluid Delivery Devices

    $5,250.00

    Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S.

    December 1, 2015
    Find out more

  • Asia-Pacific Disease Incidence and Prevalence

    $5,250.00

    The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.

    January 1, 2016
    Find out more

  • Global Radiation Therapy Systems Market, March 2016

    $3,750.00

    This report covers the large, highly competitive, technology driven Global Market for Radiation Therapy Systems—valued at nearly $4.3 billion in 2015.

    March 1, 2016
    Find out more

  • U.S. Markets for Interventional Cardiology Products, April 2016

    $4,750.00

    In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S.

    April 1, 2016
    Find out more

  • U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management

    $4,750.00

    More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually.

    April 4, 2016
    Find out more

  • Global Neurostimulation Devices Market, June 2016

    $4,750.00

    The large and burgeoning global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide.  Despite lingering economic uncertainty and financial constraints that have affected many other medical device markets, this market is undergoing significant technological advancement due to heavy R&D and investment efforts by dozens of innovative startups and leading medical device companies.

    June 1, 2016
    Find out more

  • U.S. Markets for Respiratory Care Products, June 2016

    $4,750.00

    The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.4 billion in 2015.

    June 20, 2016
    Find out more

  • U.S. Markets for Respiratory Care Products

    $4,750.00

    The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.9 billion in 2015, and is expected to climb at a rate of 7% over the forecast period.

    June 20, 2016
    Find out more

  • International Markets for Vascular Access Site Closure Devices — June 2016

    $4,750.00

    Cardiovascular diseases (CVDs) are the leading causes of death throughout the world.  Based on Datamonitor Healthcare estimates, approximately 500 million CVD-related cases occurred in the United States (U.S.), China, Japan, and the five major countries of Europe (France, Germany, Italy, Spain, and the United Kingdom [U.K.]).

    June 27, 2016
    Find out more

  • International Markets for Vascular Access Site Closure Devices

    $4,750.00

    Cardiovascular diseases (CVDs) are the leading causes of death throughout the world.  Based on Datamonitor Healthcare estimates, approximately 500 million CVD-related cases occurred in the United States (U.S.), China, Japan, and the five major countries of Europe (France, Germany, Italy, Spain, and the United Kingdom [U.K.]).

    June 30, 2016
    Find out more

  • Brexit and the life sciences: What lies ahead?

    $700.00

    The UK’s surprise decision to leave the EU has caused a great deal of uncertainty about the country’s future, not least among those working in the UK biopharmaceutical and broader life sciences industry.

    August 23, 2016
    Find out more

  • US Neurointerventional Devices Market, September 2016

    $4,750.00

    Neurointerventional radiology/surgery, or neurovascular intervention, is a relatively new medical specialty employing minimally invasive endovascular techniques to treat vascular diseases of the brain.

    September 21, 2016
    Find out more

  • US Neurointerventional Devices Market

    $4,750.00

    Neurointerventional radiology/surgery, or neurovascular intervention, is a relatively new medical specialty employing minimally invasive endovascular techniques to treat vascular diseases of the brain. Neurointerventional devices, which contributed sales of more than $870m in the US in 2015, involve a variety of standard and application-specific transcatheter tools and techniques for the treatment of cerebrovascular pathologies (such as aneurysms, arteriovenous malformations [AVMs], and acute and chronic thromboembolic and atherosclerotic occlusions) that prompt clinically significant distortions of cerebral blood flow and carry a high risk of catastrophic breakdowns of cerebrovascular circulation manifested by hemorrhagic or ischemic stroke.

    September 21, 2016
    Find out more

  • U.S. Markets for Advanced Wound Care Products

    $4,750.00

    U.S. Markets for Advanced Wound Care Products

    September 22, 2016
    Find out more

  • U.S. Markets for Stroke Management

    $4,750.00

    The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke.  Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke.

    September 22, 2016
    Find out more

  • The Global Molecular Diagnostics Market

    $6,250.00

    The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.

    September 22, 2016
    Find out more

  • U.S. Markets for Obesity Drugs & Devices

    $5,250.00

    U.S. Markets for Obesity Drugs & Devices

    September 22, 2016
    Find out more

  • U.S. Markets for Critical Care Patient Management Products

    $4,750.00

    This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for critical care patient management products.

    September 22, 2016
    Find out more

  • U.S. Neurostimulation Devices Market, June 2015

    $5,250.00

    An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime.

    September 22, 2016
    Find out more

  • U.S. Markets for Sports Medicine Products

    $4,750.00

    This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. sports medicine devices market.

    September 22, 2016
    Find out more

  • U.S. Markets for Orthopedic Biologic and Tissue Engineered Products

    $4,750.00

    Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases.

    September 22, 2016
    Find out more

  • U.S. Markets for Neurosurgical and Neurointerventional Products

    $3,750.00

    This dynamic, new report from Medtech Insight includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Neurosurgical and Neurointerventional Products Market.

    September 22, 2016
    Find out more

  • U.S. Markets for Specialty Endoscopic Surgery Products

    $4,750.00

    This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, surgical procedure volumes, competitors, and opportunities in the U.S. Specialty Endoscopic Surgery Products Market.

    September 22, 2016
    Find out more

  • U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

    $3,750.00

    U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products, March 2015

    September 22, 2016
    Find out more

  • U.S. Markets for Heart Valve Disorder Management Products

    $4,750.00

    This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

    September 22, 2016
    Find out more
Page 2 of 7
Page 2 of 7‹1234›»
  • Home
  • Terms and Conditions
  • Refund policy
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • About Us
  • Discounts
  • Market Spotlight – Reports
  • twitter
  • linkedin
  • Sitemap
Datamonitor Healthcare is part of Pharma intelligence Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
  • Informa PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726
informa
Call Back
Scroll to top